An Upconversion Nanoplatform Based Multi-Effective Theatment for Parkinson's Disease

[1]  Xiaolei Wang,et al.  Upconversion nanoparticles regulated drug & gas dual-effective nanoplatform for the targeting cooperated therapy of thrombus and anticoagulation , 2022, Bioactive materials.

[2]  Zhibo Tang,et al.  Photoresponsive Vaccine‐Like CAR‐M System with High‐Efficiency Central Immune Regulation for Inflammation‐Related Depression , 2021, Advanced materials.

[3]  Yugang Wang,et al.  MOFs-based nanoagent enables dual mitochondrial damage in synergistic antitumor therapy via oxidative stress and calcium overload , 2021, Nature Communications.

[4]  N. Chen,et al.  Paeoniflorin: A neuroprotective monoterpenoid glycoside with promising anti-depressive properties. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[5]  Zongxin Ling,et al.  Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathway , 2020, Brain, Behavior, and Immunity.

[6]  Jia-You Fang,et al.  Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand , 2020, Biomaterials.

[7]  W. Bu,et al.  Near-infrared light-triggered NO release for spinal cord injury repair , 2020, Science Advances.

[8]  Cheng Peng,et al.  A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  J. Jankovic,et al.  Parkinson’s disease: etiopathogenesis and treatment , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[10]  Patrik Brundin,et al.  Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. , 2020, Clinics in geriatric medicine.

[11]  Wei Wei,et al.  Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. , 2019, Pharmacology & therapeutics.

[12]  N. Voelcker,et al.  Advances in Microfluidic Blood-Brain Barrier (BBB) Models. , 2019, Trends in biotechnology.

[13]  Changlong Hao,et al.  Chiral Core-Shell Upconversion Nanoparticle@MOF Nanoassemblies for Quantification and Bioimaging of Reactive Oxygen Species in Vivo. , 2019, Journal of the American Chemical Society.

[14]  S. Tait,et al.  Mitochondria as multifaceted regulators of cell death , 2019, Nature Reviews Molecular Cell Biology.

[15]  Nikhil Panicker,et al.  Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease , 2019, Neuron.

[16]  K. Double,et al.  Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease , 2019, Aging cell.

[17]  R. Anjum,et al.  Parkinson's disease: Mechanisms, translational models and management strategies , 2019, Life sciences.

[18]  Jian-Dong Jiang,et al.  Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin , 2019, Front. Pharmacol..

[19]  M. Schoenfisch,et al.  Nitric Oxide Therapy for Diabetic Wound Healing , 2019, Advanced healthcare materials.

[20]  B. Bloem,et al.  The Emerging Evidence of the Parkinson Pandemic , 2018, Journal of Parkinson's disease.

[21]  Yuan Cheng,et al.  ROS scavenging Mn3O4 nanozymes for in vivo anti-inflammation , 2018, Chemical science.

[22]  Kaoxiang Sun,et al.  Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease , 2018, International journal of nanomedicine.

[23]  Saeid Yeganegi,et al.  Adsorption of 5-fluorouracil, hydroxyurea and mercaptopurine drugs on zeolitic imidazolate frameworks (ZIF-7, ZIF-8 and ZIF-9) , 2017 .

[24]  M. Hallett,et al.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy , 2017, Movement disorders : official journal of the Movement Disorder Society.

[25]  Junlong Liang,et al.  Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery. , 2017, Materials science & engineering. C, Materials for biological applications.

[26]  Gang Chen,et al.  The role of nitric oxide in stroke , 2017, Medical gas research.

[27]  Qingchun Zhao,et al.  Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson's model through apoptosis inhibition and autophagy enhancement , 2017, Neuropharmacology.

[28]  Yuchi Zhang,et al.  Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease , 2017, Neuropharmacology.

[29]  J. Fernández-Ruiz,et al.  Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice. , 2016, Pharmacological research.

[30]  D. Dickson,et al.  Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons , 2016, Acta Neuropathologica.

[31]  K. Martirosyan,et al.  Depth-Resolved Multispectral Sub-Surface Imaging Using Multifunctional Upconversion Phosphors with Paramagnetic Properties. , 2015, ACS applied materials & interfaces.

[32]  S. Xiong,et al.  Mitochondria-mediated apoptosis in mammals , 2014, Protein & Cell.

[33]  R. Bartlett,et al.  Long-term nitric oxide release and elevated temperature stability with S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As polymer. , 2013, Biomaterials.

[34]  Juliet M. Taylor,et al.  Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease , 2013, Neurochemistry International.

[35]  R. Challiss,et al.  Nitric Oxide Synthesis and cGMP Production Is Important for Neurite Growth and Synapse Remodeling after Axotomy , 2013, The Journal of Neuroscience.

[36]  John-Christopher Boyer,et al.  Near infrared light triggered release of biomacromolecules from hydrogels loaded with upconversion nanoparticles. , 2012, Journal of the American Chemical Society.

[37]  Cunhai Dong,et al.  Self-focusing by Ostwald ripening: a strategy for layer-by-layer epitaxial growth on upconverting nanocrystals. , 2012, Journal of the American Chemical Society.

[38]  J. M. Kikkawa,et al.  A generalized ligand-exchange strategy enabling sequential surface functionalization of colloidal nanocrystals. , 2011, Journal of the American Chemical Society.

[39]  Cai Song,et al.  Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease , 2009, Physiology & Behavior.

[40]  Wei Lu,et al.  Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Xiaohua Cao,et al.  Inducible and Selective Erasure of Memories in the Mouse Brain via Chemical-Genetic Manipulation , 2008, Neuron.

[42]  J. Jankovic.  Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[43]  R. Kuner,et al.  Regulation of motor performance and striatal function by synaptic scaffolding proteins of the Homer1 family. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Bartosz,et al.  On the specificity of 4-amino-5-methylamino-2',7'-difluorofluorescein as a probe for nitric oxide. , 2005, Free radical biology & medicine.

[45]  M. Meyerhoff,et al.  Controlled photoinitiated release of nitric oxide from polymer films containing S-nitroso-N-acetyl-DL-penicillamine derivatized fumed silica filler. , 2004, Journal of the American Chemical Society.

[46]  E. Melamed,et al.  Apoptosis and Parkinson's disease , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[47]  E. Hirsch,et al.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Haruhiko Akiyama,et al.  Rate of cell death in parkinsonism indicates active neuropathological process , 1988, Annals of neurology.

[49]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[50]  E Ray Dorsey,et al.  The Parkinson Pandemic-A Call to Action. , 2018, JAMA neurology.

[51]  Chen Jiang,et al.  The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. , 2008, Biomaterials.

[52]  Rongqin Huang,et al.  Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain. , 2007, Journal of biomedical science.

[53]  W. Tatton,et al.  Apoptosis in Parkinson's disease: Signals for neuronal degradation , 2003, Annals of neurology.